Stocks News

LAST PRICE
126.9500
TODAY'S CHANGE (%)
Trending Up1.8500 (1.4788%)

Bid / Lots
126.8300/ 7
Ask / Lots
127.0200/ 3
Open / Previous Close
125.7600 / 125.1000
Day Range
Low 124.9100
High 127.2000
52 Week Range
Low 99.0600
High 134.1700
Volume
427,592
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ Jazz Pharmaceuticals Price Target Maintained With a $200.00/Share by HC Wainwright & Co., from 9 hours ago by Dow Jones
  9 hours ago by Dow Jones
  Companies Mentioned: JAZZ
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/JAZZ/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 22, 2024 04:42 ET (09:42 GMT)
Yesterday
- DJ Jazz Pharmaceuticals Price Target Maintained With a $207.00/Share by Needham, from 1:06PM ET on Thursday Nov 21, 2024 by Dow Jones
  1:06PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: JAZZ
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/JAZZ/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 21, 2024 13:06 ET (18:06 GMT)
- DJ Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK, from 9:30AM ET on Thursday Nov 21, 2024 by Dow Jones
  9:30AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: JAZZ, ZYME, BGNE
  
  By Ben Glickman
  
  Shares of Zymeworks rose early Thursday after the cancer therapy it is developing with Jazz Pharmaceuticals received accelerated regulatory approval for treating forms of biliary tract cancer.
- Sector Update: Health Care Stocks Rise Pre-Bell Thursday, from 9:13AM ET on Thursday Nov 21, 2024 by MT Newswires
  9:13AM ET on Thursday Nov 21, 2024 by MT Newswires
  Companies Mentioned: IBB, JAZZ, PFE, XLV, ZYME, ZLAB, NRIX
  09:13 AM EST, 11/21/2024 (MT Newswires) -- Health care stocks rose in pre-bell hours Thursday with the Health Care Select Sector SPDR Fund (XLV) 0.3% higher and the iShares Biotechnology ETF (IBB) up 0.5% recently. Zymeworks (ZYME) and Jazz Pharmace...
- DJ Jazz Pharmaceuticals Price Target Cut to $163.00/Share From $166.00 by Piper Sandler, from 9:06AM ET on Thursday Nov 21, 2024 by Dow Jones
  9:06AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: JAZZ
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/JAZZ/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 21, 2024 09:06 ET (14:06 GMT)

Today
- Sector Update: Health Care Stocks Advance Premarket Friday, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: AMRX, HALO, IBB, EVO, XLV, EYEN
Yesterday
- Amneal Pharmaceuticals Gets FDA Nod for Diabetes Injections, Resubmits Application for Migraine Treatment, from 20 hours ago by MT Newswires
  20 hours ago by MT Newswires
  Companies Mentioned: AMRX
- DJ Amneal Resubmits New Drug Application for Migraine Treatment, Diabetes Drug Is Approved, from 20 hours ago by Dow Jones
  20 hours ago by Dow Jones
  Companies Mentioned: AMRX
- Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist, from 21 hours ago by Dow Jones
  21 hours ago by Dow Jones
  Companies Mentioned: AMRX
Nov 20, 2024
- John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum), from 8:50AM ET on Wednesday Nov 20, 2024 by CNW Group
  8:50AM ET on Wednesday Nov 20, 2024 by CNW Group
  Companies Mentioned: NDOI
- John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX(R) (collagenase clostridium histolyticum), from 8:50AM ET on Wednesday Nov 20, 2024 by PR Newswire
  8:50AM ET on Wednesday Nov 20, 2024 by PR Newswire
  Companies Mentioned: NDOI
Nov 18, 2024
- Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling, from 5:30PM ET on Monday Nov 18, 2024 by PR Newswire
  5:30PM ET on Monday Nov 18, 2024 by PR Newswire
  Companies Mentioned: NDOI
- Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling, from 5:30PM ET on Monday Nov 18, 2024 by Dow Jones
  5:30PM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: NDOI
Nov 15, 2024
- Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada, from 7:30AM ET on Friday Nov 15, 2024 by CNW Group
  7:30AM ET on Friday Nov 15, 2024 by CNW Group
  Companies Mentioned: NDOI
- Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora(R) Cream in Canada, from 7:30AM ET on Friday Nov 15, 2024 by PR Newswire
  7:30AM ET on Friday Nov 15, 2024 by PR Newswire
  Companies Mentioned: NDOI

Jazz Pharmaceuticals PLC
NASDAQ:JAZZUnited States

Search Criteria

Today

DJ Jazz Pharmaceuticals Price Target Maintained With a $200.00/Share by HC Wainwright & Co., from 9 hours ago by Dow Jones

Yesterday

DJ Jazz Pharmaceuticals Price Target Maintained With a $207.00/Share by Needham, from 1:06PM ET on Thursday Nov 21, 2024 by Dow Jones

DJ Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK, from 9:30AM ET on Thursday Nov 21, 2024 by Dow Jones

Sector Update: Health Care Stocks Rise Pre-Bell Thursday, from 9:13AM ET on Thursday Nov 21, 2024 by MT Newswires

DJ Jazz Pharmaceuticals Price Target Cut to $163.00/Share From $166.00 by Piper Sandler, from 9:06AM ET on Thursday Nov 21, 2024 by Dow Jones

Peers Headlines

Today

Sector Update: Health Care Stocks Advance Premarket Friday, from 4 hours ago by MT Newswires

Yesterday

Amneal Pharmaceuticals Gets FDA Nod for Diabetes Injections, Resubmits Application for Migraine Treatment, from 20 hours ago by MT Newswires

DJ Amneal Resubmits New Drug Application for Migraine Treatment, Diabetes Drug Is Approved, from 20 hours ago by Dow Jones

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist, from 21 hours ago by Dow Jones

Nov 20, 2024

John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum), from 8:50AM ET on Wednesday Nov 20, 2024 by CNW Group

John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX(R) (collagenase clostridium histolyticum), from 8:50AM ET on Wednesday Nov 20, 2024 by PR Newswire

Nov 18, 2024

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling, from 5:30PM ET on Monday Nov 18, 2024 by PR Newswire

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling, from 5:30PM ET on Monday Nov 18, 2024 by Dow Jones

Nov 15, 2024

Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada, from 7:30AM ET on Friday Nov 15, 2024 by CNW Group

Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora(R) Cream in Canada, from 7:30AM ET on Friday Nov 15, 2024 by PR Newswire